About 20 Mg Irinotecan Injection IP
Buy 20 Mg Irinotecan Injection IP at an unbeatable price-an uncommon solution for advanced oncology needs. This invincible formulation comes in a single dose, 2 ml sterile glass vial, delivering incomparable clinical efficacy for the treatment of metastatic colorectal cancer. The injection contains Irinotecan Hydrochloride Trihydrate, compatible with both 5% dextrose and 0.9% sodium chloride, ensuring seamless intravenous administration. Ready to use and hospital-exclusive, it is odorless, clear, and pale yellow, with a 24-month shelf life. Offer available for distributors, exporters, suppliers, and traders across India.
Distinctive Features and Clinical Application
20 Mg Irinotecan Injection IP is renowned for its ready-to-use, sterile, single-dose vial that simplifies hospital oncology workflows. Specifically indicated for metastatic colorectal cancer, it acts as a potent topoisomerase I inhibitor, disrupting cancer cell DNA replication. Its compatibility with standard IV solutions like 5% dextrose and 0.9% sodium chloride makes it highly versatile. Delivered in a glass vial, this pale yellow solution is odorless and ensures precise enzymatic action for chemotherapy regimens.
Sample Policy, Payment Terms, and Supply Logistics
Our sample policy allows for verified Purchase Orders prior to dispatch-designed to meet the requirements of hospitals and healthcare traders. Stock is kept ready, ensuring fast fulfillment upon order confirmation. We guarantee reliable Goods Transport using certified channels. Flexible payment terms are available to suit distributors, exporters, and suppliers. With robust supply ability across India, we maintain product integrity by storing vials below 25C and protecting each from light, ensuring a shelf life of 24 months.
FAQ's of 20 Mg Irinotecan Injection IP:
Q: How is the 20 Mg Irinotecan Injection IP administered to patients?
A: The 20 Mg Irinotecan Injection IP is administered intravenously, following hospital protocols and under physician supervision. Compatibility with 5% dextrose and 0.9% sodium chloride enables tailored IV preparation.
Q: What specific condition does this injection treat?
A: This injection is indicated for the treatment of metastatic colorectal cancer, providing targeted chemotherapy through its DNA topoisomerase I inhibitory action.
Q: When is a prescription required for this product?
A: A prescription is required at all times for the purchase, supply, or administration of 20 Mg Irinotecan Injection IP, as it is intended strictly for hospital use by licensed healthcare practitioners.
Q: Where should the Irinotecan Injection be stored?
A: The injection must be stored below 25C and protected from light to ensure optimal sterility and maintain its shelf life of up to 24 months.
Q: What is the process for obtaining a sample or placing an order?
A: Samples are provided following a verified Purchase Order. Stock is maintained and ready for supply, with prompt goods transport arranged upon payment confirmation and order processing.
Q: What are the advantages of choosing this Irinotecan Injection formulation?
A: Benefits include its ready-to-use, single dose format, high compatibility with IV solutions, odorless and sterile presentation, and extended shelf life-making it ideal for hospital oncology practices in India.